Empagliflozin reduces albuminuria: a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial
Research output: Contribution to journal › Editorial › Research
Documents
- Empagliflozin reduces albuminuria—a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial
Final published version, 111 KB, application/octet-stream
| Original language | English |
|---|---|
| Article number | 478 |
| Journal | Journal of Translational Medicine |
| Volume | 5 |
| Issue number | 23 |
| Number of pages | 4 |
| ISSN | 2305-5839 |
| DOIs | |
| Publication status | Published - 2017 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 188530464